Results 191 to 200 of about 354,322 (345)
Genomic Analyses of SLAMF7 CAR-T Cells Manufactured by Sleeping Beauty Transposon Gene Transfer for Immunotherapy of Multiple Myeloma [PDF]
Csaba Miskey +9 more
openalex +1 more source
Targeting a nucleotide‐sensitive groove on Hsp70 that binds the Bim BH3 helix, we integrate structures, biophysics, and SAR from peptides, fragments, and phenalene‐dicarbonitrile “wedges.” These disrupt the Hsp70–Bim complex with sub‐µM cellular engagement and in vivo activity while sparing Hsp90/mortalin.
Emadeldin M. Kamel +5 more
wiley +1 more source
[Myeloid-derived suppressor cells in peripheral blood of multiple myeloma].
Lin Zhou +7 more
openalex +2 more sources
5PSQ-053 Adaptation of prophylaxis against varicella–zoster virus in patients with multiple myeloma [PDF]
Ismael Espejo +6 more
openalex +1 more source
Abstract Background Osteoporosis fractures pose a significant public health concern, leading to substantial morbidity and mortality rates. The emerging evidence on the potential link between gut microbiota, proteins, and osteoporosis fractures suggests a complex relationship that warrants further investigation.
Qiong Wang +6 more
wiley +1 more source
CELMoD-antibody conjugates unlock a CD38 feedback loop in multiple myeloma. [PDF]
Jin J.
europepmc +1 more source
Recent Progress in the Development of Metal‐Based Radiosensitizations for Cancer Therapy: A Review
ABSTRACT Radiotherapy (RT) remains an indispensable means in cancer treatment; however, its therapeutic efficacy is often limited by tumor radioresistance and side effect of damage to healthy tissue. The advances in nanotechnology have propelled metal radiosensitizers to forefront of precision medicine.
Xiao‐Xia Wu +12 more
wiley +1 more source
Adipokines as Prognostic Biomarkers in Multiple Myeloma: A Case-Control Study. [PDF]
Obajed Al-Ali N +10 more
europepmc +1 more source
This review highlights recent advances in nanomedicine that enhance chimeric antigen receptor (CAR) T cell therapy against solid tumors. It discusses key barriers to CAR T cell efficacy and outlines nanotechnology‐based strategies to improve tumor targeting, remodel the immunosuppressive microenvironment, and integrate nanomaterials into CAR T cell ...
Stephen O’Rourke +3 more
wiley +1 more source
Moderate-Severe Thrombocytopenia Portends Poor Outcomes in Multiple Myeloma. [PDF]
Ferri GM +6 more
europepmc +1 more source

